[1] GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol, 2024; 23, 973−1003. doi:  10.1016/S1474-4422(24)00369-7
[2] GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024; 403, 2162−203. doi:  10.1016/S0140-6736(24)00933-4
[3] Feigin VL, Brainin M, Norrving B, et al. World stroke organization: global stroke fact sheet 2025. Int J Stroke, 2025; 20, 132−44. doi:  10.1177/17474930241308142
[4] Rochmah TN, Rahmawati IT, Dahlui M, et al. Economic burden of stroke disease: a systematic review. Int J Environ Res Public Health, 2021; 18, 7552. doi:  10.3390/ijerph18147552
[5] World Health Organization. The incidence of cerebral stroke in China ranks first in the world. https://www.vbdata.cn/newsDetail/2538510a6afb11e9ac2e00163e0cb09b. [2025-03-12]. (In Chinese)
[6] Tang CH, Guo L, Li Q, et al. Interpretation on the report of global stroke data 2022. J Diagn Concepts Pract, 2023; 22, 238−46. (In Chinese)
[7] Wang YT, Ge Y, Yan W, et al. From smoke to stroke: quantifying the impact of smoking on stroke prevalence. BMC Public Health, 2024; 24, 2301. doi:  10.1186/s12889-024-19754-6
[8] Zuurbier CCM, Bourcier R, Constant Dit Beaufils P, et al. Number of affected relatives, age, smoking, and hypertension prediction score for intracranial aneurysms in persons with a family history for subarachnoid hemorrhage. Stroke, 2022; 53, 1645−50. doi:  10.1161/STROKEAHA.121.034612
[9] World Health Organization. Important factors of Tobacco. https://www.who.int/zh/news-room/fact-sheets/detail/tobacco. [2025-02-20]. (In Chinese)
[10] Thun M, Peto R, Boreham J, et al. Stages of the cigarette epidemic on entering its second century. Tob Control, 2012; 21, 96−101. doi:  10.1136/tobaccocontrol-2011-050294
[11] World Health Organization. WHO global report on trends in prevalence of tobacco use 2000−2030. World Health Organization. 2024.
[12] Liu LQ, Liu XY, Ma XY, et al. Analysis of the associations of indoor air pollution and tobacco use with morbidity of lung cancer in Xuanwei, China. Sci Total Environ, 2020; 717, 135232. doi:  10.1016/j.scitotenv.2019.135232
[13] Asian Pacific Post. Air pollution chokes Asia. https://asianpacificpost.com/article/9950-air-pollution-chokes-asia.html. [2025-02-20].
[14] Zhao J, Shi YL, Wang YT, et al. Lung cancer risk attributable to active smoking in China: a systematic review and meta-analysis. Biomed Environ Sci, 2023; 36, 850−61.
[15] Pesch B, Kendzia B, Gustavsson P, et al. Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer, 2012; 131, 1210−9. doi:  10.1002/ijc.27339
[16] Seow WJ, Hu W, Vermeulen R, et al. Household air pollution and lung cancer in China: a review of studies in Xuanwei. Chin J Cancer, 2014; 33, 471−5.
[17] Wang XY, Liu X, O'donnell MJ, et al. Tobacco use and risk of acute stroke in 32 countries in the INTERSTROKE study: a case-control study. eClinicalMedicine, 2024; 70, 102515. doi:  10.1016/j.eclinm.2024.102515
[18] Zhao K, Li J, Zhou P, et al. Is electronic cigarette use a risk factor for stroke? A systematic review and meta-analysis. Tob Induc Dis, 2022; 20, 101.
[19] Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol, 2004; 43, 1731−7. doi:  10.1016/j.jacc.2003.12.047
[20] Liu T, David SP, Tyndale RF, et al. Associations of CYP2A6 genotype with smoking behaviors in southern China. Addiction, 2011; 106, 985−94. doi:  10.1111/j.1360-0443.2010.03353.x
[21] Ando M, Hamajima N, Ariyoshi N, et al. Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults. J Epidemiol, 2003; 13, 176−81. doi:  10.2188/jea.13.176
[22] Huang YH, Hu QR, Wei ZX, et al. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility. Open Life Sci, 2023; 18, 20220680. doi:  10.1515/biol-2022-0680
[23] Takeshita T, Morimoto K, Yamaguchi N, et al. Relationships between cigarette smoking, alcohol drinking, the ALDH2 genotype and adenomatous types of colorectal polyps in male self-defense force officials. J Epidemiol, 2000; 10, 366−71. doi:  10.2188/jea.10.366
[24] World Health Organization. WHO report on the global tobacco epidemic 2019: offer help to quit tobacco use. https://www.who.int/publications/i/item/9789241516204. [2025-02-20].
[25] Lam TH, Li ZB, Ho SY, et al. Smoking, quitting and mortality in an elderly cohort of 56 000 Hong Kong Chinese. Tob Control, 2007; 16, 182−9. doi:  10.1136/tc.2006.019505
[26] Lam TH, Ho SY, Hedley AJ, et al. Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998. BMJ, 2001; 323, 361. doi:  10.1136/bmj.323.7309.361
[27] Ueshima H, Choudhury SR, Okayama A, et al. Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke, 2004; 35, 1836−41. doi:  10.1161/01.STR.0000131747.84423.74
[28] Tamaki J, Ueshima H, Hayakawa T, et al. Effect of conventional risk factors for excess cardiovascular death in men: NIPPON DATA80. Circ J, 2006; 70, 370−5. doi:  10.1253/circj.70.370
[29] Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet, 2011; 378, 1297−305. doi:  10.1016/S0140-6736(11)60781-2
[30] Appelman Y, van Rijn BB, ten Haaf ME, et al. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis, 2015; 241, 211−8. doi:  10.1016/j.atherosclerosis.2015.01.027
[31] Yen ML, Yang CY, Yen BL, et al. Increased high sensitivity C-reactive protein and neutrophil count are related to increased standard cardiovascular risk factors in healthy Chinese men. Int J Cardiol, 2006; 110, 191−8. doi:  10.1016/j.ijcard.2005.07.034
[32] Ramsay S, Lowe GDO, Whincup PH, et al. Relationships of inflammatory and haemostatic markers with social class: results from a population-based study of older men. Atherosclerosis, 2008; 197, 654−61. doi:  10.1016/j.atherosclerosis.2007.02.022
[33] Mooney LA, Perera FP, van Bennekum AM, et al. Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers. Cancer Epidemiol Biomarkers Prev, 2001; 10, 641−8.
[34] Corona G, Rastrelli G, Di Pasquale G, et al. Endogenous testosterone levels and cardiovascular risk: meta-analysis of observational studies. J Sex Med, 2018; 15, 1260−71. doi:  10.1016/j.jsxm.2018.06.012